By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > Investing > Canada Reveals Drug Plan, Estimated Annual Cost in C$1.5 Billion Range
Investing

Canada Reveals Drug Plan, Estimated Annual Cost in C$1.5 Billion Range

News Room
Last updated: 2024/03/01 at 8:56 AM
By News Room
Share
3 Min Read
SHARE

By Paul Vieira


OTTAWA- Canada’s minority Liberal government on Thursday revealed a slimmed-down version of a single-payer universal drug plan, with an initial price tag that represents a fraction of the cost that budget watchers anticipated.

The drug plan meets a demand by a smaller left-wing party, the New Democratic Party, in exchange for its support in the legislature to prop up the minority Liberal administration. Canada’s parliamentary budget watchdog had estimated the annual cost of a universal drug plan – which would cover a gamut of medicines – starting at about 11 billion Canadian dollars, or the equivalent of $8.1 billion.

The initial proposal, as set out in legislation introduced Thursday, intends to initially cover a number of birth-control and diabetes medications. Canada Health Minister Mark Holland told reporters an early estimate of the annual cost could be in the C$1.5 billion range, although he warned that could change. “It’s not an insignificant cost.”

He added the cost is contingent on what’s negotiated with each of the individual provinces and territories, which in Canada have jurisdiction over delivering health care to residents. Holland added he didn’t expect Finance Minister Chrystia Freeland to book a cost in the 2024-25 fiscal year for the drug plan when the annual budget plan is revealed, expected in the coming weeks.

Fiscal-policy watchers awaited the cost of the drug plan, and how it might affect the federal government’s public finances in the years ahead. Freeland has pledged to keep the budget deficit this fiscal year to C$40 billion, and lower the debt-to-gross domestic product ratio after it peaks at 42.7% in 2024-25.

In a separate announcement, Canada said it would reallocate over the next three years about C$10.5 billion of spending from nonpriority items to top priorities, among them health care.

Holland said once initial negotiations are reached with the provinces and territories, that officials would examine whether other drugs could be covered.


Write to Paul Vieira at [email protected]


Read the full article here

News Room March 1, 2024 March 1, 2024
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
REX American Resources Corporation 2026 Q3 – Results – Earnings Call Presentation (NYSE:REX) 2025-12-05

This article was written byFollowSeeking Alpha's transcripts team is responsible for the…

AI won’t take your job – but someone using it will

Watch full video on YouTube

Could Crypto-Backed Mortgages Put The U.S. Housing Market At Risk?

Watch full video on YouTube

Aurubis AG (AIAGY) Q4 2025 Earnings Call Transcript

FollowPlay Earnings CallPlay Earnings Call Aurubis AG (OTCPK:AIAGY) Q4 2025 Earnings Call…

A bartenders’ guide to the best cocktails in Washington

This article is part of FT Globetrotter’s guide to Washington DCWashington is…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Nursing Home Stocks Could Suffer from this Medicaid Spending Remedy

By News Room
Investing

Bitcoin Drops Below $90,000 Again. What Could Move It Next.

By News Room
Investing

These Stocks Are Moving the Most Today: Marvell, Nvidia, Broadcom, GM, Tesla, MongoDB, Burlington, and More

By News Room
Investing

Nvidia Stock Falls as Marvell Earnings Compound AI Gloom. The Rising Risks for Chips.

By News Room
Investing

This analyst says Tesla deliveries will be 16% below expectations. Musk is part of the problem.

By News Room
Investing

BP CEO was awarded no bonus pay from oil giant’s financial performance

By News Room
Investing

Shares of Starlink’s European competitor have tripled. CEO says it can do the job in Ukraine.

By News Room
Investing

GE Vernova Stock Rises as Analyst Flips to Upgrade After Rating Cut

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?